BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16712450)

  • 1. Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer.
    Díaz-Cruz ES; Brueggemeier RW
    Anticancer Agents Med Chem; 2006 May; 6(3):221-32. PubMed ID: 16712450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between aromatase and cyclooxygenases in breast cancer: potential for new therapeutic approaches.
    Brueggemeier RW; Díaz-Cruz ES
    Minerva Endocrinol; 2006 Mar; 31(1):13-26. PubMed ID: 16498361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
    Brueggemeier RW; Díaz-Cruz ES; Li PK; Sugimoto Y; Lin YC; Shapiro CL
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):129-36. PubMed ID: 15964185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
    Richards JA; Petrel TA; Brueggemeier RW
    J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatase and COX in breast cancer: enzyme inhibitors and beyond.
    Brueggemeier RW; Su B; Sugimoto Y; Díaz-Cruz ES; Davis DD
    J Steroid Biochem Mol Biol; 2007; 106(1-5):16-23. PubMed ID: 17616393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells.
    Díaz-Cruz ES; Shapiro CL; Brueggemeier RW
    J Clin Endocrinol Metab; 2005 May; 90(5):2563-70. PubMed ID: 15687328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase and cyclooxygenases: enzymes in breast cancer.
    Brueggemeier RW; Richards JA; Petrel TA
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):501-7. PubMed ID: 14623550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
    Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective regulation of aromatase expression for drug discovery.
    Brueggemeier RW; Su B; Darby MV; Sugimoto Y
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):207-10. PubMed ID: 19931613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.
    Brueggemeier RW; Quinn AL; Parrett ML; Joarder FS; Harris RE; Robertson FM
    Cancer Lett; 1999 Jun; 140(1-2):27-35. PubMed ID: 10403538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase and breast cancer.
    Chen S
    Front Biosci; 1998 Aug; 3():d922-33. PubMed ID: 9696881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pharmacology of aromatase and its regulation by endogenous and exogenous agents.
    Brueggemeier RW; Richards JA; Joomprabutra S; Bhat AS; Whetstone JL
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):75-84. PubMed ID: 11850210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.
    Subbaramaiah K; Hudis C; Chang SH; Hla T; Dannenberg AJ
    J Biol Chem; 2008 Feb; 283(6):3433-3444. PubMed ID: 18083712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase gene expression in adipose tissue: relationship to breast cancer.
    Simpson ER; Mahendroo MS; Nichols JE; Bulun SE
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():75-83. PubMed ID: 7874190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of cyclooxygenase-2 in breast cancer.
    Denkert C; Winzer KJ; Hauptmann S
    Clin Breast Cancer; 2004 Feb; 4(6):428-33. PubMed ID: 15023244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of aromatase expression in human tissues.
    Bulun SE; Simpson ER
    Breast Cancer Res Treat; 1994; 30(1):19-29. PubMed ID: 7949202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of estrogen and their importance.
    Simpson ER
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cyclooxygenase-2-dependent signaling via cyclic AMP response element activation on aromatase up-regulation by o,p'-DDT in human breast cancer cells.
    Han EH; Kim HG; Hwang YP; Choi JH; Im JH; Park B; Yang JH; Jeong TC; Jeong HG
    Toxicol Lett; 2010 Oct; 198(3):331-41. PubMed ID: 20678559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.